Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,

Detalhes bibliográficos
Autor(a) principal: Rovesti,Miriam
Data de Publicação: 2021
Outros Autores: Zucchi,Alfredo, Feliciani,Claudio, Satolli,Francesca
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000500565
Resumo: Abstract The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod.
id SBD-1_d790f7b92ecaf74c7c399d318b2f7ca9
oai_identifier_str oai:scielo:S0365-05962021000500565
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,DermoscopyImiquimodMelanomaAbstract The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod.Sociedade Brasileira de Dermatologia2021-10-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000500565Anais Brasileiros de Dermatologia v.96 n.5 2021reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1016/j.abd.2020.08.025info:eu-repo/semantics/openAccessRovesti,MiriamZucchi,AlfredoFeliciani,ClaudioSatolli,Francescaeng2021-10-14T00:00:00Zoai:scielo:S0365-05962021000500565Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2021-10-14T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,
title Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,
spellingShingle Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,
Rovesti,Miriam
Dermoscopy
Imiquimod
Melanoma
title_short Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,
title_full Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,
title_fullStr Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,
title_full_unstemmed Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,
title_sort Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod,
author Rovesti,Miriam
author_facet Rovesti,Miriam
Zucchi,Alfredo
Feliciani,Claudio
Satolli,Francesca
author_role author
author2 Zucchi,Alfredo
Feliciani,Claudio
Satolli,Francesca
author2_role author
author
author
dc.contributor.author.fl_str_mv Rovesti,Miriam
Zucchi,Alfredo
Feliciani,Claudio
Satolli,Francesca
dc.subject.por.fl_str_mv Dermoscopy
Imiquimod
Melanoma
topic Dermoscopy
Imiquimod
Melanoma
description Abstract The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000500565
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000500565
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.abd.2020.08.025
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.96 n.5 2021
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126424584552448

Registros relacionados